Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: routine clinical pharmacokinetic data.
about
Recommended reading in population pharmacokinetic pharmacodynamicsNonlinear pharmacokinetics of therapeutic proteins resulting from receptor mediated endocytosisApplication of NONMEM to routine bioavailability data.Mixed Effects Modeling Using Stochastic Differential Equations: Illustrated by Pharmacokinetic Data of Nicotinic Acid in Obese Zucker Rats.Designs for population pharmacodynamics: value of pharmacokinetic data and population analysis.Population pharmacokinetics of clozapine and its primary metabolite norclozapine in Chinese patients with schizophrenia.A novel Gibbs maximum a posteriori (GMAP) approach on Bayesian nonlinear mixed-effects population pharmacokinetics (PK) modelsPopulation pharmacokinetics of lamivudine in adult human immunodeficiency virus-infected patients enrolled in two phase III clinical trials.Screening for sources of interindividual pharmacokinetic variability in anticancer drug therapy: utility of population analysis.Interpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpoint.Pharmacokinetics and pharmacodynamics of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis in the randomized ADVANCE study.Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic study.Population pharmacokinetic modeling of the Qishe pill in three major traditional Chinese medicine-defined constitutional types of healthy Chinese subjects: study protocol for a randomized controlled trialA Nonlinear Mixed Effects Approach for Modeling the Cell-To-Cell Variability of Mig1 Dynamics in YeastPopulation pharmacokinetics I: background, concepts, and models.Population pharmacokinetics II: estimation methods.Time-dependent clearance of mycophenolic acid in renal transplant recipientsShrinkage in nonlinear mixed-effects population models: quantification, influencing factors, and impactA pragmatic approach to the design of population pharmacokinetic studies.Overview of model-building strategies in population PK/PD analyses: 2002-2004 literature survey.Anticoagulation therapy advisor: a decision-support system for heparin therapy during ECMO.Analysis of pharmacokinetic data using parametric models. II. Point estimates of an individual's parameters.Population pharmacokinetic data and parameter estimation based on their first two statistical moments.Population-based assessments of clinical drug-drug interactions: qualitative indices or quantitative measures?Effects of intravitreal dexamethasone on concentration of intravitreal vancomycin in experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis.On the recording of sample times and parameter estimation from repeated measures pharmacokinetic data.Population pharmacokinetics of sifalimumab, an investigational anti-interferon-α monoclonal antibody, in systemic lupus erythematosus.Population Pharmacokinetics of Piperaquine in Young Ugandan Children Treated With Dihydroartemisinin-Piperaquine for Uncomplicated Malaria.Development of a population pharmacokinetic model of prucalopride in children with functional constipation.Quantitative Assessment of Population Variability in Hepatic Drug Metabolism Using a Perfused Three-Dimensional Human Liver Microphysiological System.Population pharmacokinetics of cyclosporine in transplant recipients.Bringing Model-Based Prediction to Oncology Clinical Practice: A Review of Pharmacometrics Principles and Applications.Methods and strategies for assessing uncontrolled drug-drug interactions in population pharmacokinetic analyses: results from the International Society of Pharmacometrics (ISOP) Working Group.Children in clinical trials: towards evidence-based pediatric pharmacotherapy using pharmacokinetic-pharmacodynamic modeling.The impact of composite AUC estimates on the prediction of systemic exposure in toxicology experiments.Predicting CD4 T-Cell Reconstitution Following Pediatric Hematopoietic Stem Cell Transplantation.Population pharmacokinetics.Assessment of penetrant and vehicle mixture properties on transdermal permeability using a mixed effect pharmacokinetic model of ex vivo porcine skin.Teaching application of clinical pharmacology skills using unusual observations from clozapine overdoses.Evolution of pharmacokinetics and pharmacokinetic/dynamic correlations during the 20th century.
P2860
Q24647906-88426047-E273-4E1C-A471-26885F891B3EQ30489162-262A982A-A78D-4C52-9715-CD4F352B8AFDQ30597644-2579D178-45BD-4DA1-BEF2-74855352B262Q30895231-9B885A1B-E8F6-4F74-B73F-76221CE5770BQ33364323-815D1FA7-B516-4039-AAE1-A44081CB329EQ33571417-5782FF3A-A7E1-40D6-82FE-DA231CEB7434Q33692989-8B8B3674-F26F-4651-ABB4-59BFA7EC5442Q33978372-1647B55C-C5DA-43C0-8087-6D77C37A6A40Q34211026-ADC61B03-DA73-48F2-9E3C-0DE67D16D5D8Q34996894-7B04DBDA-305A-4BE7-856D-74445B48FE24Q35135977-764BE997-ECDC-4842-92B3-9AADA894A5CCQ35154257-46B7263B-2C19-4CDE-B946-89BE67070BE1Q35154416-16EBB999-D387-4CF8-B799-C1A3F9CE44ECQ35609824-1D5D7CFD-5D49-4CAF-9794-4E9EE712A7FFQ35870696-943157A5-A7B3-4C2C-AA53-6B212F112AE6Q35887615-5D8281B0-230B-4CC2-971B-B80FC9B49E8AQ36024478-172B439E-E34A-4072-83C6-F9709B695E7FQ36331482-519AA338-F942-4D6E-B973-51123D54F4B8Q36341611-420FD3AA-74F0-41BA-838C-35AF939AE805Q36388088-89749D10-A534-47D0-BDF2-FF6C66320777Q36470006-90DB96FB-B38A-4378-91E5-5AEBED4857DEQ36484805-2A18AEB5-BD13-438C-8467-58E4B434FC6DQ36627168-D87FF3BF-98A0-4FD1-9590-F92B1B4BB2C3Q36628026-722E1E3D-8319-4A47-9137-6CDD42C94088Q36754030-C9B6F523-61D4-4DA6-B2DD-C20DF3C2CE14Q36883130-EF5F216B-9E6D-4880-BC49-D9318BE77C37Q37298794-41728B10-91C0-4A03-B0A6-695F5DF31D2AQ37383670-AD6CF554-984A-412D-A035-189E29ED3D41Q37421978-DF77C68E-6A95-4F6D-B530-CC1238CF1964Q37540180-3E3D66CE-F71F-4E43-9ED4-51B52020D9F8Q38115174-32A2D0F3-B4F7-4B42-8620-AC0C2315FDD5Q38289581-B8EFADF5-4DCB-4958-83F3-ECCB0268B72CQ38720418-4F94DBC9-722C-477B-BF00-EA3D3865007CQ38857191-ECC132CD-5C44-41B7-96BD-CC69927AE921Q39018559-08944223-C201-4081-9CD1-C343F764F75FQ39027873-C9E2DB76-33FF-45D4-A623-CF5013A89BC4Q39571946-7C77B014-EE7E-40F0-9B05-CDDED2AD2BC0Q39721162-BA8B36C6-0EC0-4723-920D-E58CDA1D316AQ40535225-22F91E38-F31D-4A36-B55E-A9B167EC2189Q40749507-2B68A92B-3CDA-48B7-8222-FEC8950A781D
P2860
Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: routine clinical pharmacokinetic data.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
1983年论文
@zh
1983年论文
@zh-cn
name
Evaluation of methods for esti ...... clinical pharmacokinetic data.
@ast
Evaluation of methods for esti ...... clinical pharmacokinetic data.
@en
type
label
Evaluation of methods for esti ...... clinical pharmacokinetic data.
@ast
Evaluation of methods for esti ...... clinical pharmacokinetic data.
@en
prefLabel
Evaluation of methods for esti ...... clinical pharmacokinetic data.
@ast
Evaluation of methods for esti ...... clinical pharmacokinetic data.
@en
P2860
P356
P1476
Evaluation of methods for esti ...... clinical pharmacokinetic data.
@en
P2093
P2860
P2888
P304
P356
10.1007/BF01061870
P577
1983-06-01T00:00:00Z